Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
AvenCell bags $112M to flick 'switchable' CAR-Ts in the clinic
AvenCell has secured the funds as the Novo Holdings-backed biotech seeks proof it can generate CAR-T cells that can be turned “on” inside a patient.
James Waldron
Oct 22, 2024 6:00am
Booster takes off with protein degraders for neurodegeneration
Oct 10, 2024 9:25am
Stroke devicemaker Route 92 Medical raises $50M to go global
Sep 23, 2024 11:34am
Asceneuron raises $100M series C for ph. 2 Alzheimer's trial
Jul 16, 2024 3:00am
Myricx secures $114M series A to push ADCs into clinic
Jul 8, 2024 1:00am
Reunion nets $103M, one of the largest for a psychedelic biotech
May 2, 2024 6:30am
